Sygnature Discovery Limited
Emily Wright is an accomplished Lead Scientist at Sygnature Discovery, where employment began in May 2020. Prior to this role, Emily served as a Senior Scientist 1 in Translational Oncology at Alderley Park Limited from June 2019 to May 2020 and as an In Vivo Scientist at AstraZeneca from August 2007 to December 2017. Additional experience includes the position of Licensed Animal Technician at Agenda Life Sciences from January 2018 to May 2019. Emily holds an HNC in Biomedical Sciences, General from North Trafford College, completed between 2007 and 2009, and graduated from Eaton Bank School in 2007.
This person is not in any teams
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.